These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8477122)

  • 1. Naloxone and dementia.
    Stowe C; Gora ML
    Ann Pharmacother; 1993 Apr; 27(4):447-8. PubMed ID: 8477122
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 3. Low- and high-dose naloxone in dementia of the Alzheimer type.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of clinical benefit from naloxone in a dementia day hospital.
    Panella JJ; Blass JP
    Ann Neurol; 1984 Mar; 15(3):308. PubMed ID: 6721454
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of naloxone in neurology].
    Mendel T; Barańska-Gieruszczak M
    Neurol Neurochir Pol; 1988; 22(6):553-7. PubMed ID: 3077436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementia-related diseases. Propentofyllin--a neuroprotective glia cell modulator].
    Nervenarzt; 1998 Feb; 69(2 Suppl Propentofy):1-4. PubMed ID: 9532231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of drugs against dementia].
    Engedal K; Braekhus A; Gjerstad L
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1641-2. PubMed ID: 15229711
    [No Abstract]   [Full Text] [Related]  

  • 8. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alzheimer dementia: new perspectives in drug therapy].
    Krankenpfl J; 1997 Oct; 35(10):393-5. PubMed ID: 9400159
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer disease: time to improve its diagnosis and treatment.
    Salloway S; Correia S
    Cleve Clin J Med; 2009 Jan; 76(1):49-58. PubMed ID: 19122111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Whitehouse PJ; Orgogozo JM; Becker RE; Gauthier S; Pontecorvo M; Erzigkeit H; Rogers S; Mohs RC; Bodick N; Bruno G; Dal-Bianco P
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():56-60. PubMed ID: 9305519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of Alzheimer dementia].
    Skausig OB; Laugesem LP; Jensen T
    Ugeskr Laeger; 2003 Jul; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug discovery in dementia: the role of rodent models.
    Van Dam D; De Deyn PP
    Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of rispolept in mental disorders in patients with Alzheimer and vascular types of dementia].
    Shamreĭ VK; Kolchev AI; Dobrovol'skaia NV
    Voen Med Zh; 2002 Nov; 323(11):47-51. PubMed ID: 12532483
    [No Abstract]   [Full Text] [Related]  

  • 15. [The challenge of Alzheimer dementia].
    Pharm Unserer Zeit; 2003; 32(1):77. PubMed ID: 12577765
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alzheimer dementia. Intervening as early as possible].
    MMW Fortschr Med; 2002 Jan; 144(1-2):67. PubMed ID: 11847891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dementia--don't forget the vitamins].
    Lökk J
    Lakartidningen; 2003 Nov; 100(47):3892. PubMed ID: 14719249
    [No Abstract]   [Full Text] [Related]  

  • 19. The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():2-5. PubMed ID: 9305506
    [No Abstract]   [Full Text] [Related]  

  • 20. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.